Record Information |
---|
Version | 2.0 |
---|
Created at | 2024-09-10 18:57:01 UTC |
---|
Updated at | 2024-09-10 18:57:01 UTC |
---|
NP-MRD ID | NP0334570 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | Rosiglitazone |
---|
Description | Rosiglitazone belongs to the class of organic compounds known as phenol ethers. These are aromatic compounds containing an ether group substituted with a benzene ring. Rosiglitazone was first documented in 2024 (PMID: 39307787). Based on a literature review a small amount of articles have been published on Rosiglitazone (PMID: 39304103) (PMID: 39301639) (PMID: 39299820) (PMID: 39289148). |
---|
Structure | CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1 InChI=1/C18H19N3O3S/c1-21(16-4-2-3-9-19-16)10-11-24-14-7-5-13(6-8-14)12-15-17(22)20-18(23)25-15/h2-9,15H,10-12H2,1H3,(H,20,22,23) |
---|
Synonyms | Not Available |
---|
Chemical Formula | C18H19N3O3S |
---|
Average Mass | 357.4300 Da |
---|
Monoisotopic Mass | 357.11471 Da |
---|
IUPAC Name | 5-[(4-{2-[methyl(pyridin-2-yl)amino]ethoxy}phenyl)methyl]-1,3-thiazolidine-2,4-dione |
---|
Traditional Name | rosiglitazone |
---|
CAS Registry Number | Not Available |
---|
SMILES | CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1 |
---|
InChI Identifier | InChI=1/C18H19N3O3S/c1-21(16-4-2-3-9-19-16)10-11-24-14-7-5-13(6-8-14)12-15-17(22)20-18(23)25-15/h2-9,15H,10-12H2,1H3,(H,20,22,23) |
---|
InChI Key | YASAKCUCGLMORW-UHFFFAOYNA-N |
---|
Experimental Spectra |
---|
|
| Not Available | Predicted Spectra |
---|
|
| Not Available | Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | Not Available |
---|
Chemical Taxonomy |
---|
Description | This compound belongs to the class of organic compounds known as phenol ethers. These are aromatic compounds containing an ether group substituted with a benzene ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Phenol ethers |
---|
Sub Class | Not Available |
---|
Direct Parent | Phenol ethers |
---|
Alternative Parents | |
---|
Substituents | - Phenoxy compound
- Phenol ether
- Dialkylarylamine
- Alkyl aryl ether
- Aminopyridine
- Monocyclic benzene moiety
- Pyridine
- Imidolactam
- Heteroaromatic compound
- Meta-thiazoline
- Carbonic acid derivative
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Azacycle
- Ether
- Organoheterocyclic compound
- Hydrocarbon derivative
- Organic oxide
- Organooxygen compound
- Organonitrogen compound
- Organic nitrogen compound
- Carbonyl group
- Organopnictogen compound
- Organic oxygen compound
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Li H, Xie JZ, Fan RX, Yang L, Zhou QY, Zhou NN: [Effect of Sijunzi Decoction on intestinal barrier of type 2 diabetic mice]. Zhongguo Zhong Yao Za Zhi. 2024 Aug;49(16):4510-4520. doi: 10.19540/j.cnki.cjcmm.20240429.401. [PubMed:39307787 ]
- Wu Q, Jiao Y, Li J, Ma Y, Wang J, Luo M, Wang Y, Fan X, Liu C: Flavokawain B is an effective natural peroxisome proliferator-activated receptor gamma-selective agonist with a strong glucose-lowering effect. Biochem Pharmacol. 2024 Sep 18;229:116548. doi: 10.1016/j.bcp.2024.116548. [PubMed:39304103 ]
- Sun Y, Lian Y, Mei X, Xia J, Feng L, Gao J, Xu H, Zhang X, Yang H, Hao X, Feng Y: Cinobufagin inhibits M2‑like tumor‑associated macrophage polarization to attenuate the invasion and migration of lung cancer cells. Int J Oncol. 2024 Nov;65(5):102. doi: 10.3892/ijo.2024.5690. Epub 2024 Sep 20. [PubMed:39301639 ]
- Cuzzocrea S, Pisano B, Dugo L, Ianaro A, Maffia P, Patel NSA, Di Paola R, Ialenti A, Genovese T, Chatterjee PK, Di Rosa M, Caputi AP, Thiemermann C: Retraction notice to "Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammation" [Eur. J. Pharmacol 483 (1) (2024) 79-93]. Eur J Pharmacol. 2024 Sep 18:177006. doi: 10.1016/j.ejphar.2024.177006. [PubMed:39299820 ]
- Li H, Liao X, Lan M, He J, Gao J, Fan Z, Huang J, Wu X, Chen J, Sun G: Arctigenin Modulates Adipogenic-Osteogenic Balance in the Bone Marrow Microenvironment of Ovariectomized Rats via the MEK1/PPARgamma/Wnt/beta-Catenin Pathway. Chem Biol Drug Des. 2024 Sep;104(3):e14625. doi: 10.1111/cbdd.14625. [PubMed:39289148 ]
|
---|